Call for evidence to support ACMD’s review of changes to legislation on the use of cannabis-based products for medicinal purposes (CBPMs).

The Advisory Council on the Misuse of Drugs (ACMD) is currently reviewing the impact of the 2018 changes to the Misuse of Drugs Regulations 2001 which included cannabis-based products for medicinal u…